在骨关节炎中,TRPV4介导的线粒体功能障碍通过Drp1-HK2轴诱导皮质和软骨退化
Zijian Yan1, Zili He1, Hongyi Jiang1
1Department of Orthopaedics Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
International immunopharmacology
|July 28, 2023
概括
暂时受体潜在化物4 (TRPV4) 通道的激活通过诱导状细胞灭和软骨损伤促进骨关节炎. 抑制TRPV4可以逆转这些影响,这表明骨关节炎的治疗潜力.
科学领域:
- 生物医学研究的研究.
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,与状细胞灭有关.
- NLRP3炎症酶和短暂受体潜在化物4 (TRPV4) 通道都与OA的发病有关.
研究的目的:
- 调查TRPV4在状细胞灭和软骨退化中的作用.
- 阐明TRPV4影响OA进展的分子机制.
主要方法:
- 研究了脂聚糖 (LPS) 诱导的皮रोप托斯和软骨细胞中的软骨退化.
- 利用前交叉带切割 (ACLT) 鼠标模型来研究TRPV4抑制.
- 检查了TRPV4介导的信号通路,包括CaMKII,Drp1转位和线粒体功能障碍.
主要成果:
- 由LPS诱导的线粒体反应性氧物种 (mtROS) 积累加剧了状细胞烧灭和软骨退化.
- 通过CaMKII通路,TRPV4诱导了与胺相关的蛋白1 (Drp1) 的线粒体转位,导致线粒体功能障碍和热.
- 在ACLT小鼠模型中,TRPV4抑制改善了DRp1相关的软骨细胞灭和软骨退化.
结论:
- 在甲状腺炎中,TRPV4在状细胞灭和细胞外基质降解中发挥着关键作用.
- 抑制TRPV4通过减轻状细胞亡和软骨损伤,证明了对骨关节炎的治疗疗效.
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K


